Free Trial

Green Thumb Industries Inc. (OTCMKTS:GTBIF) Sees Significant Decline in Short Interest

Green Thumb Industries logo with Medical background

Key Points

  • Green Thumb Industries experienced a 77.5% decline in short interest as of July 31, with only 11,600 shares sold short, indicating increased investor confidence.
  • Benchmark reissued a "buy" rating on Green Thumb Industries, showing positive analyst sentiment despite the company's recent quarterly earnings miss.
  • The company reported a net revenue of $293.26 million for the quarter, exceeding estimates, but had a loss of $0.01 earnings per share, missing expectations by $0.05.
  • MarketBeat previews top five stocks to own in October.

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 11,600 shares, adeclineof77.5% from the July 15th total of 51,600 shares. Based on an average daily volume of 1,166,300 shares, the short-interest ratio is presently 0.0 days. Approximately0.0% of the company's stock are short sold. Approximately0.0% of the company's stock are short sold. Based on an average daily volume of 1,166,300 shares, the short-interest ratio is presently 0.0 days.

Green Thumb Industries Stock Performance

Shares of GTBIF traded up $0.5725 during trading hours on Wednesday, reaching $7.97. 599,638 shares of the company traded hands, compared to its average volume of 495,675. The stock's fifty day moving average is $6.12 and its 200 day moving average is $6.05. The stock has a market cap of $1.69 billion, a P/E ratio of 72.46 and a beta of 1.18. Green Thumb Industries has a 1-year low of $4.63 and a 1-year high of $11.50.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). The company had revenue of $293.26 million for the quarter, compared to analyst estimates of $280.66 million. Green Thumb Industries had a net margin of 2.51% and a return on equity of 1.62%. On average, equities research analysts predict that Green Thumb Industries will post 0.32 EPS for the current year.

Analysts Set New Price Targets

Separately, Benchmark reissued a "buy" rating on shares of Green Thumb Industries in a research report on Monday, August 11th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company's stock. According to data from MarketBeat.com, Green Thumb Industries has a consensus rating of "Strong Buy".

Get Our Latest Analysis on GTBIF

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

See Also

Should You Invest $1,000 in Green Thumb Industries Right Now?

Before you consider Green Thumb Industries, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.

While Green Thumb Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.